|
PLEKHG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35540000229173E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.855470E-03 |
| Normal-vs-Stage2 |
3.881800E-02 |
| Normal-vs-Stage3 |
1.482400E-02 |
| Normal-vs-Stage4 |
1.023800E-01 |
| Stage1-vs-Stage2 |
3.154800E-01 |
| Stage1-vs-Stage3 |
1.935990E-01 |
| Stage1-vs-Stage4 |
4.178600E-01 |
| Stage2-vs-Stage3 |
7.658000E-01 |
| Stage2-vs-Stage4 |
9.691200E-01 |
| Stage3-vs-Stage4 |
8.389400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03200000001191E-06 |
| Normal-vs-AfricanAmerican |
8.515400E-03 |
| Normal-vs-Asian |
2.466600E-01 |
| Caucasian-vs-AfricanAmerican |
7.390200E-01 |
| Caucasian-vs-Asian |
4.353400E-01 |
| AfricanAmerican-vs-Asian |
4.111600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.59780000031607E-07 |
| Normal-vs-Female |
6.169400E-04 |
| Male-vs-Female |
3.714600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.583400E-03 |
| Normal-vs-Extreme_Weight |
9.380300E-03 |
| Normal-vs-Obese |
1.277600E-03 |
| Normal-vs-Extreme_Obese |
3.276600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.075400E-01 |
| Normal_Weight-vs-Obese |
7.333600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.884800E-01 |
| Extreme_Weight-vs-Obese |
1.783190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.589200E-01 |
| Obese-vs-Extreme_Obese |
1.874030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.759590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.04950000000093E-05 |
| Normal-vs-Age(61-80Yrs) |
1.212620E-04 |
| Normal-vs-Age(81-100Yrs) |
8.601900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.575400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.341200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.344400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.903600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.574400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.207400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.05629999999935E-05 |
| Normal-VS-Type2 PRCC |
1.022180E-03 |
| Normal-VS-KIRP CIMP |
4.397000E-01 |
| Normal-VS-Unclassified PRCC |
2.577800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.481400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.066330E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.214610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.956800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.696800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.084200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.681690E-02 |
| Normal-vs-N1 |
2.292200E-02 |
| Normal-vs-N2 |
2.538400E-01 |
| N0-vs-N1 |
2.885400E-01 |
| N0-vs-N2 |
2.328800E-01 |
| N1-vs-N2 |
7.007600E-01 |
|
|
